Vie Ventures

Vie Ventures operates at the intersection of venture capital and disease philanthropy.

Our team leverages decades of experience, a proven track record in life sciences venture capital, a returns-oriented approach, and a network of strategic collaborators from across the biotech and disease philanthropy ecosystems to advance life-changing therapies and cures for patients.

Learn more

about partnering with Vie Ventures

A Panel Discussion About Our Strategy​

Learn more

about our discussion with Sean Doherty

Latest News

Feb 24, 2026

In Vivo – 20 Voices: What Does 2026 Hold For Biopharma?

Read more
Feb 19, 2026

Treg pioneer Bluestone joins Vie Ventures as it builds autoimmune portfolio

Read more
Feb 19, 2026

Vie Ventures Names Jeff Bluestone, PhD, as Managing Director

Read more
Jan 21, 2026

Interview with Vie Ventures Co-Founders Dr. Steven St. Peter and Dr. Luke Evnin and Senior Advisor Dr. Louis DeGennaro

Read more
Jan 5, 2026

Catalytic Capital in Biotech & VC Philanthropy: Redefining purpose-aligned capital in biotech

Read more
Dec 5, 2025

Two veterans from MPM have launched a new VC firm, Vie Ventures, that will focus on investing in the I&I space – and it will leverage collaborations with disease specific philanthropies

Read more